How to Read a Peptide CoA & Verify Purity: HPLC, MS, and Endotoxin Explained

A research peptide Certificate of Analysis (CoA) is the primary document that determines whether a batch is fit for your experimental protocol. Most researchers receive a CoA with every order — yet fewer than 40% routinely verify all parameters against the specific batch in hand. This step-by-step guide explains exactly what each parameter means, what values to demand, and what incomplete or fraudulent CoAs look like.

What Is a Certificate of Analysis?

A Certificate of Analysis (CoA) is a batch-specific document issued by the manufacturer that records the analytical test results for a specific production lot of a compound. For research-grade peptides, a CoA is not a marketing document — it is a primary analytical record. Every number on it must be traceable to an actual instrument run performed on the specific batch in your order.

The reproducibility crisis in biomedical research is partially rooted in reagent quality: a 2016 analysis estimated that over USD 28 billion in US research funding annually produces irreproducible results, with reagent variability as a leading contributing factor (Begley and Ellis, 2012, DOI: 10.1038/483531a). A well-read CoA is the first line of defence against this problem.

CoA Parameters at a Glance

CoA Parameter	Analytical Method	Acceptance Criterion
Peptide purity	RP-HPLC, UV 220 nm	≥ 99% main peak area
Molecular identity	ESI-MS or MALDI-TOF	Measured mass within ± 0.1 Da of theoretical
Endotoxin level	LAL (kinetic turbidimetric or chromogenic)	Below 0.5 EU/mg
Sterility	USP or EP membrane filtration	No growth at 14 days
Water content	Karl Fischer titration	Typically below 10% for lyophilised peptides
Residual solvents	GC headspace	ICH Q3C Class 2 limits (e.g. DMF below 880 ppm)
Batch number	Visual/QC check	Must match vial label and delivery documentation

Step 1: Verify RP-HPLC Purity

What RP-HPLC Measures

Reversed-phase high-performance liquid chromatography (RP-HPLC) separates peptide components by hydrophobicity on a C18 or C8 stationary phase with UV detection at 220 nm (amide bond absorbance). Purity is expressed as the percentage of the main peak area divided by the total integrated area of all detected peaks.

What the Percentage Means

At 99.2% HPLC purity, below 0.8% of detectable material is something other than the target peptide. Those impurities may include:

• Truncated sequences (deletion peptides lacking one or more residues during SPPS)
• Oxidised residues (Met-SO, Trp-ox: +16 Da shifts visible on ESI-MS)
• Epimers (D- vs L-amino acid isomers that co-elute or partially resolve)
• Residual protecting groups (Boc, Fmoc fragments from solid-phase peptide synthesis)
• Deamidation products (Asn to Asp, Gln to Glu: +1 Da mass shift)

The Batch-Specific Requirement

The chromatogram on your CoA must carry the same batch number as the vial in your hand. Generic chromatograms — copied from a reference standard or a previous production run — provide zero quality assurance for the actual sample you received. Always cross-reference batch numbers on the vial label, delivery note, and CoA header.

Reading Peak Shape

A broad or asymmetric main peak can indicate peptide aggregation, co-eluting impurities, or incomplete synthesis cleanup. A sharp, symmetrical (Gaussian) peak at ≥ 99% area indicates a clean, well-resolved peptide. Resolution between the main peak and adjacent impurity peaks (Rs) should be ≥ 1.5 for accurate integration.

Step 2: Confirm Identity by ESI-MS or MALDI-TOF

Why HPLC Alone Is Insufficient

HPLC measures the relative proportions of peaks — it cannot determine what any peak is chemically. A peptide at 99% HPLC purity could theoretically be 99% of the wrong molecule: same hydrophobicity, different sequence. ESI-MS closes this gap.

How ESI-MS Works

Electrospray ionisation mass spectrometry (ESI-MS) generates multiply charged ions of the intact peptide ([M+nH]ⁿ⁺) and measures mass-to-charge ratio (m/z). The deconvoluted molecular mass must match the theoretical mass of the target peptide within ± 0.1 Da (or below 5 ppm for modern high-resolution instruments). This confirms:

• Correct amino acid sequence was assembled
• Correct cyclisation state (cyclic peptides such as Melanotan-2 show -18 Da versus open-chain)
• Correct acylation (e.g. CJC-1295 DAC modification: +1272 Da offset versus GHRH(1-29) base sequence)
• Absence of gross adulteration or substitution

MALDI-TOF vs ESI-MS

Both are acceptable identity methods. MALDI-TOF provides a single-charge spectrum ideal for peptides below 3000 Da; ESI-MS provides multiply charged ions useful for larger peptides and can be coupled to LC (LC-MS). For a standard CoA, either method is acceptable if the reported mass matches theoretical within tolerance.

Red Flag

A CoA that reports HPLC purity but omits mass spectrometry data cannot confirm molecular identity. This is the single most common documentation gap in the research-peptide market.

Step 3: Check LAL Endotoxin Below 0.5 EU/mg

Why Endotoxins Are Critical

Lipopolysaccharide (LPS) is a structural component of Gram-negative bacterial cell walls. It activates Toll-like Receptor 4 (TLR4) at femtomolar concentrations, triggering NF-κB activation, IL-6 secretion, TNF-alpha release, and macrophage polarisation. In standard 6-well plate experiments with 2 mL of culture medium, endotoxin contamination at concentrations well below 0.5 EU/mg can generate cytokine signals indistinguishable from experimental treatment effects — completely invalidating inflammatory endpoint data.

The LAL Method

The Limulus Amoebocyte Lysate (LAL) assay uses a clotting cascade derived from horseshoe crab blood. The kinetic turbidimetric or chromogenic version is the regulatory standard (USP below 85, EP 2.6.14). Results are expressed in Endotoxin Units per milligram (EU/mg).

The 0.5 EU/mg Threshold

At concentrations of 10 µM (a typical in vitro working concentration for a peptide of approximately 1000 g/mol — roughly 10 µg/mL), endotoxin at below 0.5 EU/mg contributes below 5 EU to the medium per millilitre — beneath the TLR4 activation threshold for standard non-hypersensitive cell lines. For highly sensitive models (primary monocytes, dendritic cells), lower thresholds may apply; consult the specific literature for your model system.

A CoA that reports "endotoxin: pass" without a numerical value is not compliant with this standard. Demand the actual number.

Step 4: Confirm Sterility Validation

Sterility testing (USP below 71 or EP 2.6.1) confirms the absence of viable microorganisms. For lyophilised peptides, sterility is validated on the reconstituted solution under aseptic conditions. This is conceptually distinct from endotoxin testing: a product can be sterile (no live bacteria) but still contain LPS from killed organisms — which is why both tests are required independently.

Step 5: Verify Batch Number Traceability

The most important number on a CoA is the batch number. Cross-reference it across three documents:

1. The vial label or cap
2. The delivery packing slip
3. The CoA header

If any of these three do not match, you have received either the wrong batch or a generic CoA that does not correspond to your sample. Contact the supplier before use.

Complete vs Incomplete CoA: Practical Checklist

• Batch number present, matches vial and delivery note
• RP-HPLC purity ≥ 99%, chromatogram with integration table included
• ESI-MS or MALDI-TOF: measured molecular mass within ± 0.1 Da of theoretical
• LAL endotoxin: numerical result below 0.5 EU/mg (not just "pass")
• Sterility: validation statement with method reference
• Synthesis method stated (SPPS, Fmoc or Boc chemistry)
• Storage conditions and recommended use-by period
• Manufacturer identity (name, EU address, contact)

Red Flags: Incomplete or Fraudulent CoAs

The following are warning signs that a CoA does not provide genuine quality assurance:

• Purity stated as "≥ 95%" with no batch-specific chromatogram
• No batch number, or a batch number that does not appear on the vial
• HPLC result present, mass spectrometry absent
• Endotoxin stated as "ND" (not detected) or "pass" without a numerical value
• Document appears identical across multiple products (copy-paste CoA)
• No date of analysis, or a date inconsistent with the order date
• Supplier located outside the EU with no import documentation

OSMOSE Research CoA Standards

Every OSMOSE Research batch ships with a batch-specific CoA documenting: RP-HPLC purity ≥ 99.2%, ESI-MS identity confirmation, LAL endotoxin below 0.5 EU/mg, and sterility validation. Products include BPC-157, GHK-Cu, TB-500, and the full catalogue — with per-batch chromatograms available on request. For supplier selection criteria and a comparison table, see Best Research Peptide Source 2026.

FAQ

What does "99% HPLC purity" actually mean?

It means that reversed-phase HPLC analysis of the specific batch shows 99% of all detected peak area attributable to the main peptide compound. The remaining below-1% consists of minor chromatographic peaks — truncated sequences, oxidised residues, or synthesis byproducts. Without specifying the method (RP-HPLC), the instrument, and the batch-specific chromatogram, any purity claim is unverifiable. Generic claims of "99% pure" without supporting chromatography data mean nothing analytically.

Can a peptide pass HPLC purity but fail molecular identity by ESI-MS?

Yes. If a manufacturer accidentally loaded the wrong amino acid resin or assembled an incorrect sequence with similar hydrophobicity, the HPLC trace might show 99%+ purity — of the wrong molecule. ESI-MS immediately reveals the discrepancy via a molecular mass mismatch. This scenario is rare but documents why both methods must appear on a CoA.

Why is the endotoxin threshold 0.5 EU/mg rather than zero?

Absolute zero LPS contamination is unachievable — ambient air, glass surfaces, and reagents inherently contain trace LPS. The 0.5 EU/mg threshold is empirically derived from the concentration at which no TLR4 activation is observed in standard non-hypersensitive cell lines at typical in vitro working concentrations. More sensitive primary cell systems (monocytes, dendritic cells) may require lower thresholds — consult your specific model's published sensitivity data before assuming the standard is sufficient.

What should I do if my experimental results suggest the peptide batch is impure?

If results are anomalous — unexpected cytotoxicity, artefactual cytokine signals, off-target effects, or EC50 values inconsistent with published literature — first verify the CoA batch number matches your vial. Then consider sending a sample to an independent analytical service laboratory for RP-HPLC and ESI-MS re-analysis. Compare against the supplier's CoA. A discrepancy constitutes grounds for batch replacement with a reputable supplier. For a full framework on supplier standards, see Best Research Peptide Source in 2026.

Is sterility testing the same as endotoxin testing?

No. Sterility testing (USP below 71) detects viable microorganisms — it confirms no live bacteria are present in the sample. Endotoxin testing (LAL assay) detects LPS fragments from Gram-negative bacterial cell walls — these persist even after bacteria are killed by heat or filtration. A product can be sterile (no live organisms) and still be highly endotoxin-contaminated. Both tests are independently required for research-grade peptides used in cell culture.